• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Anlon Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 94105.0
  • ISIN : INE0Y8W01025
15.68 0 (0.51%)
  • As on 06 Sep 2026 (EOD)

  • Today’s Low

    15.54

  • Today’s High

    15.89

  • Open

    15.68

  • Perv Close

    15.60

  • 52W Low

    9.10

  • 52W High

    17.28

Key Indicators

  • P/E(TTM)

    28.51

  • Mar.Cap (₹Cr.)

    833.42

  • Div & Yield %

    0.00

  • Book Value(₹)

    3.95

  • Debt-Equity Ratio

    0.51

  • AGM Date

    04-Sep-2026

  • EPS

    0.55

  • P/E Ratio

    28.51

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    833.42

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    106.30

  • BV (₹)

    3.90

  • Sales( ₹ in Cr.)

    176.50

  • NP (in Cr.)

    27.81

  • NP Var(%)

    36.0

  • Div%

    0.0

  • CPS (₹)

    0.50

  • EPS (₹)

    0.50

  • Traded Value (₹ in Lakhs)

    833.42

  • 52 Week High

    17.28

  • 52 Week Low

    9.10

  • Price BSE

    16.0

  • Price NSE

    16.00

  • Market Capital( in Cr.)

    833.42

  • P/C Ratio

    29.20

  • P/E Ratio

    30.60

  • Price Vs.BV

    0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 176.50 120.29 66.58 112.88 57.14 15.98
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 176.50 120.29 66.58 112.88 57.14 15.98
Other Income 0.25 0.17 0.11 0.24 0.39 0.35
Stock Adjustments 16.92 -3.30 10.39 -2.44 4.16 3.24
Total Income 193.67 117.16 77.08 110.68 61.69 19.57
EXPENDITURE :            
Raw Materials 129.76 71.29 44.05 85.51 47.49 15.06
Power and Fuel Cost 3.49 2.87 4.04 3.82 2.10 2.14
Employee Cost 5.25 4.88 4.36 3.68 2.78 3.08
Other Manufacturing Expenses 3.72 1.64 4.17 1.56 1.42 2.06
Selling and Administration Expenses 2.32 2.18 3.97 2.42 1.61 1.87
Miscellaneous Expenses 2.73 1.92 0.68 0.91 0.35 0.20
Employee Benefit Expenses 5.25 4.88 4.36 3.68 2.78 3.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 147.27 84.78 61.27 97.89 55.74 24.41
Operating Profit 46.39 32.38 15.81 12.79 5.94 -4.84
Interest 4.35 3.72 4.17 3.93 4.21 3.21
Gross Profit 42.04 28.66 11.64 8.86 1.73 -8.05
Depreciation 1.36 1.77 1.89 1.87 1.84 1.86
Profit Before Tax 40.68 26.89 9.75 6.99 -0.11 -9.91
Current Tax 11.40 6.54 0.01 1.01 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.47 -0.17 0.08 0.16 0.00 0.33
Reported Net Profit 27.81 20.52 9.66 5.82 -0.11 -10.24
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -0.02
Adjusted Net Profit 27.81 20.52 9.66 5.82 -0.11 -10.22
Adjustment below Net Profit 5.48 0.01 0.00 0.00 -0.21 0.00
P & L Balance brought forward 23.04 2.52 -7.51 -13.33 -13.02 -2.98
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 56.33 23.04 2.14 -7.51 -13.33 -13.22
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.23 5.15 6.04 4.85 -0.09 -8.53
Earnings Per Share(Adj)-Unit Curr 0.52 - - - - -
Book Value 39.47 20.18 13.14 6.15 1.30 1.39
Book Value(Adj)-Unit Curr 3.95 - - - - -

Shareholding Pattern

  • Promoter Group

    52.68%

  • Public Share Holding

    47.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 280,000,000 52.68 280,000,000 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 280,000,000 52.68 280,000,000 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,867,377 1.67 8,867,377 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 300,000 0.06 300,000 1
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,200,000 1.17 6,200,000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 15,367,377 2.89 15,367,377 9
2] Non Institution
Bodies Corporate 88,939,441 16.73 88,939,441 108
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,489,217 0.47 2,489,217 261
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 5,518,841 1.04 5,518,841 433
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 77,086,954 14.50 77,086,954 172
Individuals holding nominal share capital up to Rs. 1 lakh 62,113,170 11.69 62,110,170 33,686
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 236,147,623 44.43 236,144,623 34,660
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 531,515,000 100.00 531,512,000 34,671

Company Background

Anlon Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Anlon Healthcare Ltd
  • BSE Code : 94105.0
  • ISIN : INE0Y8W01025

  • Incorporation Year

    2013

  • Registered Office

    101/102 Silvercoin Complex Opp
    Crystal Mall Kalawad Road, Rajkot,
    Gujarat-360005

  • Telephone

    +91 281 2562538/39

  • FAX

  • Chairman

    Punitkumar R Rasadia

  • Managing Director

  • Company Secretary

    Pragada Amitabhen Chhaganbha

  • Auditor

    Kaushal Dave & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Anlon Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Anlon Healthcare 15.68 176.75 176.50 28.51 22.35
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 393.10 354.33 41.34 15.94
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77